INC Research, a therapeutically focused CRO, has appointed Robert Ryan, PhD, as vice president of regulatory strategy, consulting and submissions. Ryan will provide global leadership to position INC Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

Ryan is an experienced senior regulatory affairs executive with more than two decades of experience in the biopharmaceutical industry. He brings a unique blend of scientific and business acumen to the position, having held regulatory and executive leadership positions in both the CRO and biopharmaceutical industries with companies such as Quintiles, PPD, Celtic Therapeutics and Schwarz Pharma. Most recently, he served as chairman of the board for Levare, a CNS/pain pharmaceutical development company.